Intermuscular fat density as a novel prognostic factor in breast cancer patients treated with adjuvant chemotherapy

被引：0
|
作者：
Ye Won Jeon
Hyung Soon Park
Yousun Ko
Yu Sub Sung
Byoung Yong Shim
Young Jin Suh
Hyun A Kim
机构：
[1] The Catholic University of Korea,Department of Surgery, St. Vincent’s Hospital, College of Medicine
[2] The Catholic University of Korea,Division of Medical Oncology, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine
[3] The Catholic University of Korea,Cell Death Disease Research Center, College of Medicine
[4] Asan Institute for Life Sciences,Biomedical Research Center
[5] Asan Medical Center,Clinical Research Center
[6] Asan Medical Center,Department of Convergence Medicine
[7] University of Ulsan College of Medicine,Department of Radiology, St. Vincent’s Hospital, College of Medicine
[8] The Catholic University of Korea,undefined
来源：
Breast Cancer Research and Treatment | 2021年 / 189卷
关键词：
Breast cancer; Chemotherapy; Fat density; Visceral obesity; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：759 / 768
页数：9
相关论文
共 50 条
  • [1] Intermuscular fat density as a novel prognostic factor in breast cancer patients treated with adjuvant chemotherapy
    Jeon, Ye Won
    Park, Hyung Soon
    Ko, Yousun
    Sung, Yu Sub
    Shim, Byoung Yong
    Suh, Young Jin
    Kim, Hyun A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (03) : 759 - 768
  • [2] POST-CHEMOTHERAPY AMENORRHEA AS A PROGNOSTIC FACTOR IN BREAST-CANCER PATIENTS TREATED WITH ADJUVANT CHEMOTHERAPY
    TOMA, S
    COIALBU, T
    REPETTO, L
    GIACCHERO, A
    COSTANTINI, M
    ROSSO, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 121 - 121
  • [3] PROGNOSTIC FACTORS IN BREAST CANCER PATIENTS TREATED WITH ADJUVANT TRASTUZUMAB AND CHEMOTHERAPY
    Kurebayashi, J.
    Kanomata, N.
    Yamashita, T.
    Mizutoh, A.
    Moriya, T.
    Sonoo, H.
    [J]. BREAST, 2013, 22 : S51 - S51
  • [4] Prognostic Impact of IGKC in Breast Cancer Patients Treated with Adjuvant Chemotherapy
    Heimes, Anne-Sophie
    Kraemer, Hannah
    Hasenburg, Annette
    Schmidt, Marcus
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 210 - 210
  • [5] Prognostic Impact of Immunoglobulin Kappa C in Breast Cancer Patients Treated with Adjuvant Chemotherapy
    Heimes, Anne-Sophie
    Kraemer, Hannah
    Haertner, Franziska
    Almstedt, Katrin
    Krajnak, Slavomir
    Battista, Marco J.
    Brenner, Walburgis
    Hasenburg, Annette
    Schmidt, Marcus
    [J]. BREAST CARE, 2021, 16 (05) : 444 - 450
  • [6] Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy
    Headley, JA
    Theriault, RL
    LeBlanc, AD
    Vassilopoulou-Sellin, R
    Hortobagyi, GN
    [J]. CANCER INVESTIGATION, 1998, 16 (01) : 6 - 11
  • [7] Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breast Cancer Patients without Diabetes
    Ahn, Ha Rim
    Kang, Sang Yull
    Youn, Hyun Jo
    Jung, Sung Hoo
    [J]. JOURNAL OF BREAST CANCER, 2020, 23 (04) : 398 - 409
  • [8] OBESITY AS AN ADVERSE PROGNOSTIC FACTOR FOR PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    BASTARRACHEA, J
    HORTOBAGYI, GN
    SMITH, TL
    KAU, SWC
    BUZDAR, AU
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (01) : 18 - 25
  • [9] Age as a prognostic factor for patients with non-metastatic breast cancer treated with adjuvant chemotherapy after initial surgery.
    Lluch-Hernandez, A
    Martinez-Dueñas, E
    Prosper, F
    Garcia, T
    Sastre, JM
    Azagra, P
    Chirivella, I
    Garcia-Conde, J
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 21
  • [10] A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy
    Rella, C
    Coviello, M
    Giotta, F
    Maiello, E
    Colavito, P
    Colangelo, D
    Quaranta, M
    Colucci, G
    Schittulli, F
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 40 (02) : 151 - 159
12345